Detalhe da pesquisa
1.
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Cancer
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470379
2.
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol.
BMC Cancer
; 23(1): 554, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328818
3.
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer
; 23(1): 1080, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946136
4.
Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.
Oncology
; 100(12): 633-644, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283345
5.
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations.
Future Oncol
; 18(30): 3377-3387, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039910
6.
Activity of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma: A Phase 2 Study of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG).
JAMA Oncol
; 8(10): 1420-1425, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980618
7.
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Eur J Cancer
; 165: 13-24, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189537
8.
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(21)2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771635
9.
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Eur J Cancer
; 150: 108-118, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895682
10.
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Eur J Cancer
; 148: 359-370, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780664
11.
Implementation and use of whole exome sequencing for metastatic solid cancer.
EBioMedicine
; 51: 102624, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31923800
12.
Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study.
J Extracell Vesicles
; 9(1): 1766192, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32595915
13.
Limbs and trunk soft tissue sarcoma systematic local and remote monitoring by MRI and thoraco-abdomino-pelvic scanner: A single-centre retrospective study.
Eur J Surg Oncol
; 45(7): 1274-1280, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765271
14.
Corrigendum to "Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer": [ESMO Open 3 (2018) e000375].
ESMO Open
; 8(2): 101185, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868156
15.
Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study.
Oncoimmunology
; 7(9): e1474319, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228942
16.
Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer.
ESMO Open
; 3(4): e000375, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29942666
17.
Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma.
JCO Precis Oncol
; 6: e2100417, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319964
18.
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Eur J Cancer
; 86: 28-36, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950146
19.
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification.
Eur J Cancer
; 87: 131-139, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29145039
20.
Prospective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patients.
PLoS One
; 9(8): e105907, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25170840